Development and validation of risk assessment models for diabetes-related complications based on the DCCT/EDIC data
Open accessAbstract
Aim To derive and validate a set of computational models able to assess the risk of developing complications and experiencing adverse events for patients with diabetes. The models are developed on data from the Diabetes Control and Complications Trial (DCCT) and the Epidemiology of Diabetes Interventions and Complications (EDIC) studies, and are validated on an external, retrospectively collected cohort. Methods We selected fifty-one clinical parameters measured at baseline during the DCCT as potential risk factors for the following adverse outcomes: Cardiovascular Diseases (CVD), Hypoglycemia, Ketoacidosis, Microalbuminuria, Proteinuria, Neuropathy and Retinopathy. For each outcome we applied a data-mining analysis protocol in order to identify the best-performing signature, i.e., the smallest set of clinical parameters that, considered jointly, are maximally predictive for the selected outcome. The predictive models built on the selected signatures underwent both an interval validation on the DCCT/EDIC data and an external validation on a retrospective cohort of 393 diabetes patients (49 Type I and 344 Type II) from the Chorleywood Medical Center, UK. Results The selected predictive signatures contain five to fifteen risk factors, depending on the specific outcome. Internal validation performances, as measured by the Concordance Index (CI), range from 0.62 to 0.83, indicating good predictive power. The models achieved comparable performances for the Type I and, quite surpri…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Lagani et al. (2015) used 51 clinical variables and included between five and fifteen risk factors depending on the specific outcome.
“Fifty‐one clinical variables were used in the selected predictive models and included between five and fifteen risk factors depending on the specific outcome (Lagani et al., 2015).”
From Artificial intelligence based prediction models for individuals at risk of multiple diabetic complications: A systematic review of the literature (2022) · cites this paper as Lagani et al. (2015)
Lagani et al. (2015) reported AUC for predicting neuropathy in both type 1 and type 2 diabetes: T1DM (internal) 0.6661, T1DM (external) 0.735, and T2DM (external) 0.4359.
“Lagani et al. (2015) reported AUC for predicting neuropathy in both type 1 and type 2 diabetes. T1DM (internal) was 0.6661, T1DM (external) was 0.735 and T2DM (external) was 0.4359.”
From Artificial intelligence based prediction models for individuals at risk of multiple diabetic complications: A systematic review of the literature (2022) · cites this paper as Lagani et al. (2015)
Cites
Ishwaran, H., Kogalur, U. B., Blackstone, E. H., & Lauer, M. S. (2008) · The Annals of Applied Statistics · doi:10.1214/08-aoas169 · Cited by 2,714 · see citing works
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301 · see citing works
The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy
The Diabetes Control and Complications Trial Research Group. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00001 · Cited by 602 · see citing works
(1995) · Diabetes Care · doi:10.2337/diacare.18.11.1415 · Cited by 305 · see citing works
Systematic review on urine albumin testing for early detection of diabetic complications
Newman, D., Mattock, M., Dawnay, A., Kerry, S., McGuire, A., Yaqoob, M., Hitman, G., & Hawke, C. (2005) · Health Technology Assessment · doi:10.3310/hta9300 · Cited by 192 · see citing works
The impact of mathematical modeling on the understanding of diabetes and related complications
Ajmera, I., Swat, M., Laibe, C., Le Novère, N., & Chelliah, V (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.30 · Cited by 153 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Machine learning and data mining methods in diabetes research
Kavakiotis, I., Tsave, O., Salifoglou, A., Maglaveras, N., Vlahavas, I., & Chouvarda, I. (2017) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.12.005 · Cited by 1,445 · see citing works
Gosak, L., Martinović, K., Lorber, M., & Stiglic, G. (2022) · Journal of Nursing Management · doi:10.1111/jonm.13894 · Cited by 24 · see citing works
“…on our systematic review, we found that models most often predict the risk of developing diabetic neuropathy ( n = 7) (Dagliati et al., 2018; Fan et al., 2021; Lagani et al., 2015; Liu et al., 2020; Ljubic et al., 2020; Ozdemir et al., 2020; Wang et al., 2021) and diabetic nephropathy ( n = 6).”
BackgroundMethod
- Authors
- Lagani, V., Chiarugi, F., Thomson, S., Fursse, J., Lakasing, E., Jones, R. W., & Tsamardinos, I.
- Affiliations
- Foundation for Research and Technology Hellas (GR)
- University of Crete (GR)
- Corresponding author
- Lagani, Vincenzo
- Venue
- Journal of Diabetes and its Complications
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 29
- Issue
- 4
- Pages
- 479-487
- ISSN
- 0891-6632 (ISSN-L)
- 1056-8727
- OpenAlex
- W2128708195
- Cited by
- 74
- References
- 7
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 7 · 2020: 16 · 2019: 6 · 2018: 7 · 2017: 3 · 2016: 4 · 2015: 1
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Diabetes and its Complications (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- European Commission (248590)
- EPILOGEAS GSRT ARISTEIA II (3446)
- National Institute of Health
- General Clinical Research Center Program, NCRR
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes complications, risk prediction model, Diabetes Control and Complications Trial, type 1 diabetes, type 2 diabetes, cardiovascular disease, hypoglycemia, ketoacidosis, microalbuminuria, proteinuria, diabetic neuropathy, diabetic retinopathy, external validation
- MeSH terms
- Adolescent, Adult, Computer Simulation, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Humans, Male, Prognosis, Retrospective Studies, Risk Factors, Randomized Controlled Trials as Topic, Risk Assessment, Diabetes Complications, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review